Scientists analyse structure of antibodies that could be key to more effective cancer treatments
Scientists at the Centre for Cancer Immunology have gained unprecedented new insight into the key properties of an antibody needed to fight off cancer.
Scientists at the Centre for Cancer Immunology have gained unprecedented new insight into the key properties of an antibody needed to fight off cancer.
Researchers at the Centre for Cancer Immunology are applying an immunotherapy treatment to an often-incurable form of cancer in a new clinical trial opening in Southampton.
Research led by the Centre for Cancer Immunology could help identify patients at risk of rapid progression and resistance to therapy in chronic lymphocytic leukaemia (CLL).
New study highlights the importance of COVID-19 vaccination boosters for cancer patients.
‘Crown-like structures’ surrounding breast tumours in overweight and obese patients could hinder their response to therapy, a new Southampton study has found.
To celebrate International Clinical Trials Day today (20th May) the Southampton Clinical Trials Unit (SCTU) has launched a virtual tour of their offices in the Centre for Cancer Immunology (CCI).
A pioneer of cancer research at the Centre for Cancer Immunology has been named a Fellow of the Royal Society.
A lack of oxygen (hypoxia) makes tumours more resistant to antibody treatments, according to a new study by scientists at the Centre for Cancer Immunology.
Dr Sean Lim, based at the Centre for Cancer Immunology, has led new research that shows the weakened immune systems of blood cancer patients can improve after they receive a third COVID-19 vaccination.
Centre research, published in Communications Biology, describes the factors which control the ability of antibodies targeting CD27 to stimulate the immune system.